Altimmune, Inc.ALTNASDAQ
Loading
Year-over-year free cash flow growth rate
Percentile
P15
Within normal range
vs 2Y Ago
-3.3x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -63.48% |
| Q3 2025 | 39.48% |
| Q2 2025 | -16.73% |
| Q1 2025 | 7.80% |
| Q4 2024 | 32.65% |
| Q3 2024 | -49.76% |
| Q2 2024 | -10.70% |
| Q1 2024 | 1.06% |
| Q4 2023 | 19.30% |
| Q3 2023 | -4.73% |
| Q2 2023 | -0.53% |
| Q1 2023 | -12.19% |
| Q4 2022 | -14.78% |
| Q3 2022 | 9.65% |
| Q2 2022 | -23.55% |
| Q1 2022 | 38.81% |
| Q4 2021 | -23.64% |
| Q3 2021 | 33.00% |
| Q2 2021 | -12.00% |
| Q1 2021 | -75.86% |
| Q4 2020 | -41.45% |
| Q3 2020 | -32.14% |
| Q2 2020 | -65.41% |
| Q1 2020 | -118.76% |
| Q4 2019 | 17.73% |
| Q3 2019 | 20.72% |
| Q2 2019 | -45.15% |
| Q1 2019 | 59.00% |
| Q4 2018 | -333.43% |
| Q3 2018 | -775.14% |
| Q2 2018 | 104.18% |
| Q1 2018 | 12.59% |
| Q4 2017 | -12.92% |
| Q3 2017 | -3.48% |
| Q2 2017 | 42.01% |
| Q1 2017 | -108.61% |
| Q4 2016 | -25.65% |
| Q3 2016 | 1209.50% |
| Q2 2016 | 728.02% |
| Q1 2016 | 26.63% |